The use of intralesional recombinant human epidermal growth factor (rhEGF) in advanced diabetic foot ulcers in South Africa
Abstract
Treatment of complex diabetic foot ulcers (DFU) with intra- and perilesional injection of recombinant human epidermal growth factor (rhEGF) has been safe and effective in clinical trials. Here, we report results on the efficacy and safety of this treatment in South Africa.
